NMPA Approval

Amphotericin B Liposome for Injection

Approval Number

国药准字H20244839

Company石药集团中诺药业（石家庄）有限公司合并

Registration Date

September 10, 2024

Drug Information

Generic Name

注射用两性霉素B脂质体

Dosage Form

注射剂

Strength

50mg（5万单位）

Drug Type

化学药品

Registration Date

September 10, 2024

Company Information

Applicant Company

Company Name石药集团中诺药业（石家庄）有限公司合并

Company Address

河北省石家庄经济技术开发区扬子路88号

Manufacturing Company

Company Name石药集团中诺药业（石家庄）有限公司合并

Company Address

石家庄经济技术开发区扬子路57号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用两性霉素B脂质体 - NMPA 批准文号 | MedPath